Skip to main content
. 2023 Apr 12;11:1126066. doi: 10.3389/fpubh.2023.1126066

Table 3.

Cancer risk factors of female firefighter survey respondents, by presence and absence of cancer.

Domain of inquiry All respondents1 (n = 1,344) Respondents without cancer (n = 1,067) Respondents with cancer (n = 256) Comparison
Count (%) Count (%) Count (%) p-value
Tobacco use2,3 347 (25.8) 258 (24.2) 84 (32.8) 0.005 a
Smoke 319 (23.7) 234 (21.9) 80 (31.3) 0.428a
Smokeless 36 (2.7) 29 (2.7) 7 (2.7)
Alcohol consumption3 1,226 (91.2) 970 (90.9) 239 (93.4) 0.210a
Hormone use2 926 (68.9) 729 (68.3) 185 (72.3) 0.220a
Estrogen 560 (41.7) 435 (40.8) 118 (46.1) 0.076a
Progesterone/Progestin 558 (41.5) 448 (42.0) 106 (41.4)
Testosterone 53 (3.9) 34 (3.2) 19 (7.4)
Human growth hormone 12 (0.9) 10 (0.9) *
Androgen 8 (0.6) 6 (0.6) *
Glucocorticoid * * 0
Other4 133 (9.9) 100 (9.4) 29 (11.3)
Full-term pregnancy and delivery 609 (45.3) 456 (42.7) 143 (55.9) 0.005 a
Breastfeeding 536 (39.9) 407 (38.1) 122 (47.7) 0.201a
Family history of cancer 0.088a
Mother 277 (20.6) 222 (20.8) 55 (21.5)
Father 246 (18.3) 196 (18.4) 50 (19.5)
Sister 50 (3.7) 35 (3.3) 15 (5.9)
Brother 34 (2.5) 22 (2.1) 12 (4.7)
Mean (SD) Median (Q1, Q3) Mean (SD) Median (Q1, Q3) Mean (SD) Median (Q1, Q3)
Years since starting tobacco 24.3 (10.9) 22.9 (10.7) 28.7 (10.6) <0.001 b
Years since stopping tobacco 16.8 (11.0) 16.1 (10.6) 19.1 (11.7) 0.039 b
# Tobacco uses per day 6 (3, 10) 5 (2,10) 7 (5,15) 0.035 c
Years since starting alcohol 21.9 (10.3) 20.7 (10.0) 26.9 (9.7) <0.001 b
Years since stopping alcohol 1 (0.5, 9) 1 (0.5, 8) 4 (1, 12) 0.089c
# Alcohol consumptions/week 3 (1, 5) 3 (1, 5) 3 (1, 5) 0.575c
*

= fewer than 5.Bold p-values indicate statistical significance.

1

Responses from respondents with or without a history of cancer and/or precancer may not add up to those of all respondents, as some respondents did not answer every question.

2

Questions in which participants could select more than one option.

3

Tobacco use and alcohol consumption are “in lifetime.”

4

“Other” hormones reported included bioidenticals, hormones for IVF/fertility treatments, Fibristal for treatment of fibroids, DHEA, and contraceptives/IUD.

a

Chi-square test.

b

T-test.

c

Wilcoxon rank-sum test.